AHA/ASA guideline recommendations for prevention of stroke in women prevention

< AHA
Revision as of 20:32, 13 February 2014 by Ayokunle Olubaniyi (talk | contribs) (/* 2014 AHA/ASA Guideline Recommendations for Prevention of Stroke in Women (DO NOT EDIT){{cite journal| author=Bushnell C, McCullough LD, Awad IA, Chireau MV, Fedder WN, Furie KL et al.| title=Guidelines for the Prevention of Stroke in Women: A Statem...)
Jump to navigation Jump to search

Stroke Main page

Patient Information

Overview

Causes

Classification

Hemorrhagic stroke
Ischemic stroke

Differentiating Stroke from other Diseases

Epidemiology and Demographics

Diagnosis

NIH stroke scale
Glasgow coma scale

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

AHA/ASA guideline recommendations for prevention of stroke in women prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of AHA/ASA guideline recommendations for prevention of stroke in women prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on AHA/ASA guideline recommendations for prevention of stroke in women prevention

CDC on AHA/ASA guideline recommendations for prevention of stroke in women prevention

AHA/ASA guideline recommendations for prevention of stroke in women prevention in the news

Blogs on AHA/ASA guideline recommendations for prevention of stroke in women prevention

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for AHA/ASA guideline recommendations for prevention of stroke in women prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S [2]

2014 AHA/ASA Guideline Recommendations for Prevention of Stroke in Women (DO NOT EDIT)[1]

Class I
"1. Women with asymptomatic carotid stenosis should be screened for other treatable risk factors for stroke, and appropriate lifestyle changes and medical therapies should be instituted.[2] (Level of Evidence: C) "
"2. In women who are to undergo CEA, aspirin is recommended unless contraindicated, because aspirin was used in every major trial that demonstrated efficacy of CEA. (Level of Evidence: C) "
"3. For women with recent TIA or ischemic stroke within the past 6 months and ipsilateral severe (70%–99%) carotid artery stenosis, CEA is recommended if the perioperative morbidity and mortality risk is estimated to be <6%. (Level of Evidence: A) "
"4. For women with recent TIA or IS and ipsilateral moderate (50%–69%) carotid stenosis, CEA is recommended depending on patient-specific factors, such as age and comorbidities, if the perioperative morbidity and mortality risk is estimated to be <6%.[3] (Level of Evidence: B) "
"5. If a high-risk (ie, 10-year predicted CVD risk ≥10%) woman has an indication for aspirin but is intolerant of aspirin therapy, clopidogrel should be substituted.[4] (Level of Evidence: B) "
Class IIa
"1. Prophylactic CEA performed with <3% morbidity/mortality can be useful in highly selected patients with an asymptomatic carotid stenosis (minimum 60% by angiography, 70% by validated Doppler ultrasound). (Level of Evidence: A) "
"2. When CEA is indicated for women with TIA or stroke, surgery within 2 weeks is reasonable rather than delaying surgery, if there are no contraindications to early revascularization.[3] (Level of Evidence: B) "
"3. Aspirin therapy (75–325 mg/d) is reasonable in women with diabetes mellitus unless contraindicated.[4] (Level of Evidence: B) "
"4. Aspirin therapy can be useful in women ≥65 years of age (81 mg/d or 100 mg every other day) if BP is controlled and the benefit for IS and MI prevention is likely to outweigh the risk of gastrointestinal bleeding and hemorrhagic stroke.[4] (Level of Evidence: B) "
Class IIb
"1. Aspirin therapy may be reasonable for women <65 years of age for IS prevention. (Level of Evidence: B) "

References

  1. Bushnell C, McCullough LD, Awad IA, Chireau MV, Fedder WN, Furie KL; et al. (2014). "Guidelines for the Prevention of Stroke in Women: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association". Stroke. doi:10.1161/01.str.0000442009.06663.48. PMID 24503673.
  2. Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S; et al. (2011). "Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association". Stroke. 42 (2): 517–84. doi:10.1161/STR.0b013e3181fcb238. PMID 21127304.
  3. 3.0 3.1 Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC; et al. (2011). "Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association". Stroke. 42 (1): 227–76. doi:10.1161/STR.0b013e3181f7d043. PMID 20966421.
  4. 4.0 4.1 4.2 Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM; et al. (2011). "Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association". Circulation. 123 (11): 1243–62. doi:10.1161/CIR.0b013e31820faaf8. PMC 3182143. PMID 21325087.

Template:WS Template:WH